Systematic review of clinical outcomes in chronic obstructive pulmonary disease View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-10

AUTHORS

Shelley R. Salpeter, Nicholas S. Buckley

ABSTRACT

Much controversy surrounds the use of β-agonists in obstructive lung disease. Regular β2-agonist use in asthma results in tolerance to its effects and an increase in asthma-related deaths. Less is known about clinical outcomes in chronic obstructive pulmonary disease (COPD). This systematic review and meta-analysis evaluates the long-term effect of β2-agonist use on severe exacebations requiring hospitalization or trial with drawal, respiratory deaths, and total mortality in patients with COPD. Results for β2-agonists are compared with results for anticholinergics and inhaled corticosteroids. Pooled results from randomized controlled trials show that anticholinergics, such as tiotropium and ipratropium, significantly reduce severe exacerbations and respiratory deaths compared with placebo. Conversely, β2-agonists increase respiratory deaths, probably because of tolerance that develops to their bronchodilator and bronchoprotective effects. Anticholinergics significantly reduce exacerbations and total mortality compared with β-agonists. The combination of the two bronchodilators is not more effective than anticholinergics alone in improving long-term clinical outcomes. Inhaled corticosteroids significantly reduce severe exacerbations and the decline in lung function over time, without affecting mortality. In conclusion, inhaled anticholinergic bronchodilators and corticosteroids should be used to improve long-term clinical outcomes in patients with COPD. β-Agonists increase respiratory deaths in COPD, possibly as a result of poorer disease control. More... »

PAGES

219-230

Identifiers

URI

http://scigraph.springernature.com/pub.10.1385/criai:31:2:219

DOI

http://dx.doi.org/10.1385/criai:31:2:219

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1026725163

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/17085795


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Inhalation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenal Cortex Hormones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholinergic Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Therapy, Combination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pulmonary Disease, Chronic Obstructive", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Santa Clara Valley Medical Center, San Jose, CA", 
          "id": "http://www.grid.ac/institutes/grid.415182.b", 
          "name": [
            "Department of Medicine, Stanford University School of Medicine, Stanford", 
            "Santa Clara Valley Medical Center, San Jose, CA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salpeter", 
        "givenName": "Shelley R.", 
        "id": "sg:person.012160071167.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012160071167.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "International Baccalaureate Program, Sequoia High School, Redwood City, CA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "International Baccalaureate Program, Sequoia High School, Redwood City, CA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Buckley", 
        "givenName": "Nicholas S.", 
        "id": "sg:person.01076436625.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076436625.24"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00002512-200421060-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044511580", 
          "https://doi.org/10.2165/00002512-200421060-00005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1111/j.1525-1497.2006.00507.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030196607", 
          "https://doi.org/10.1111/j.1525-1497.2006.00507.x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2466-5-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009077314", 
          "https://doi.org/10.1186/1471-2466-5-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2466-4-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024041024", 
          "https://doi.org/10.1186/1471-2466-4-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00044011-200121120-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040752590", 
          "https://doi.org/10.2165/00044011-200121120-00006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00151829-200403040-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042323565", 
          "https://doi.org/10.2165/00151829-200403040-00005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/2211251a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053619986", 
          "https://doi.org/10.1038/2211251a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00002018-199207010-00007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053525213", 
          "https://doi.org/10.2165/00002018-199207010-00007"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-10", 
    "datePublishedReg": "2006-10-01", 
    "description": "Much controversy surrounds the use of \u03b2-agonists in obstructive lung disease. Regular \u03b22-agonist use in asthma results in tolerance to its effects and an increase in asthma-related deaths. Less is known about clinical outcomes in chronic obstructive pulmonary disease (COPD). This systematic review and meta-analysis evaluates the long-term effect of \u03b22-agonist use on severe exacebations requiring hospitalization or trial with drawal, respiratory deaths, and total mortality in patients with COPD. Results for \u03b22-agonists are compared with results for anticholinergics and inhaled corticosteroids. Pooled results from randomized controlled trials show that anticholinergics, such as tiotropium and ipratropium, significantly reduce severe exacerbations and respiratory deaths compared with placebo. Conversely, \u03b22-agonists increase respiratory deaths, probably because of tolerance that develops to their bronchodilator and bronchoprotective effects. Anticholinergics significantly reduce exacerbations and total mortality compared with \u03b2-agonists. The combination of the two bronchodilators is not more effective than anticholinergics alone in improving long-term clinical outcomes. Inhaled corticosteroids significantly reduce severe exacerbations and the decline in lung function over time, without affecting mortality. In conclusion, inhaled anticholinergic bronchodilators and corticosteroids should be used to improve long-term clinical outcomes in patients with COPD. \u03b2-Agonists increase respiratory deaths in COPD, possibly as a result of poorer disease control.", 
    "genre": "article", 
    "id": "sg:pub.10.1385/criai:31:2:219", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094155", 
        "issn": [
          "1080-0549", 
          "1559-0267"
        ], 
        "name": "Clinical Reviews in Allergy & Immunology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2-3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "keywords": [
      "chronic obstructive pulmonary disease", 
      "long-term clinical outcomes", 
      "\u03b22-agonist use", 
      "obstructive pulmonary disease", 
      "clinical outcomes", 
      "respiratory deaths", 
      "severe exacerbations", 
      "pulmonary disease", 
      "\u03b2-agonists", 
      "systematic review", 
      "total mortality", 
      "asthma-related deaths", 
      "obstructive lung disease", 
      "poor disease control", 
      "asthma results", 
      "bronchoprotective effect", 
      "lung function", 
      "anticholinergic bronchodilator", 
      "lung disease", 
      "long-term effects", 
      "anticholinergics", 
      "corticosteroids", 
      "bronchodilators", 
      "exacerbation", 
      "disease control", 
      "mortality", 
      "death", 
      "disease", 
      "outcomes", 
      "patients", 
      "trials", 
      "tiotropium", 
      "placebo", 
      "hospitalization", 
      "ipratropium", 
      "review", 
      "effect", 
      "drawal", 
      "conclusion", 
      "use", 
      "tolerance", 
      "controversy", 
      "decline", 
      "control", 
      "results", 
      "increase", 
      "combination", 
      "function", 
      "time"
    ], 
    "name": "Systematic review of clinical outcomes in chronic obstructive pulmonary disease", 
    "pagination": "219-230", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1026725163"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1385/criai:31:2:219"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "17085795"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1385/criai:31:2:219", 
      "https://app.dimensions.ai/details/publication/pub.1026725163"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_423.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1385/criai:31:2:219"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1385/criai:31:2:219'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1385/criai:31:2:219'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1385/criai:31:2:219'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1385/criai:31:2:219'


 

This table displays all metadata directly associated to this object as RDF triples.

181 TRIPLES      21 PREDICATES      90 URIs      74 LITERALS      14 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1385/criai:31:2:219 schema:about N045553b0b1b04666b05a1ce6702d0490
2 N0bd0987588e544ae9b67a778ca80d3eb
3 N255da2cdafc74749b24e8bd5af34552c
4 N358d988dc49545b8b2793bf6e8a0007f
5 N77e1a4ba2f8d40839264e916aed67d7a
6 N8e5f1172d93141f2ac0dff2bf2864c6c
7 Nf2e3171637a84a75ba40dbd51194ea9e
8 anzsrc-for:11
9 anzsrc-for:1102
10 schema:author N3d8538736da345619687d64686b4eff0
11 schema:citation sg:pub.10.1038/2211251a0
12 sg:pub.10.1111/j.1525-1497.2006.00507.x
13 sg:pub.10.1186/1471-2466-4-7
14 sg:pub.10.1186/1471-2466-5-3
15 sg:pub.10.2165/00002018-199207010-00007
16 sg:pub.10.2165/00002512-200421060-00005
17 sg:pub.10.2165/00044011-200121120-00006
18 sg:pub.10.2165/00151829-200403040-00005
19 schema:datePublished 2006-10
20 schema:datePublishedReg 2006-10-01
21 schema:description Much controversy surrounds the use of β-agonists in obstructive lung disease. Regular β2-agonist use in asthma results in tolerance to its effects and an increase in asthma-related deaths. Less is known about clinical outcomes in chronic obstructive pulmonary disease (COPD). This systematic review and meta-analysis evaluates the long-term effect of β2-agonist use on severe exacebations requiring hospitalization or trial with drawal, respiratory deaths, and total mortality in patients with COPD. Results for β2-agonists are compared with results for anticholinergics and inhaled corticosteroids. Pooled results from randomized controlled trials show that anticholinergics, such as tiotropium and ipratropium, significantly reduce severe exacerbations and respiratory deaths compared with placebo. Conversely, β2-agonists increase respiratory deaths, probably because of tolerance that develops to their bronchodilator and bronchoprotective effects. Anticholinergics significantly reduce exacerbations and total mortality compared with β-agonists. The combination of the two bronchodilators is not more effective than anticholinergics alone in improving long-term clinical outcomes. Inhaled corticosteroids significantly reduce severe exacerbations and the decline in lung function over time, without affecting mortality. In conclusion, inhaled anticholinergic bronchodilators and corticosteroids should be used to improve long-term clinical outcomes in patients with COPD. β-Agonists increase respiratory deaths in COPD, possibly as a result of poorer disease control.
22 schema:genre article
23 schema:isAccessibleForFree false
24 schema:isPartOf N1d6c3bdb0b714ed1bf9f54cfecb32f0d
25 Ncbd2296ba6114b309c2a02476ef3d85e
26 sg:journal.1094155
27 schema:keywords anticholinergic bronchodilator
28 anticholinergics
29 asthma results
30 asthma-related deaths
31 bronchodilators
32 bronchoprotective effect
33 chronic obstructive pulmonary disease
34 clinical outcomes
35 combination
36 conclusion
37 control
38 controversy
39 corticosteroids
40 death
41 decline
42 disease
43 disease control
44 drawal
45 effect
46 exacerbation
47 function
48 hospitalization
49 increase
50 ipratropium
51 long-term clinical outcomes
52 long-term effects
53 lung disease
54 lung function
55 mortality
56 obstructive lung disease
57 obstructive pulmonary disease
58 outcomes
59 patients
60 placebo
61 poor disease control
62 pulmonary disease
63 respiratory deaths
64 results
65 review
66 severe exacerbations
67 systematic review
68 time
69 tiotropium
70 tolerance
71 total mortality
72 trials
73 use
74 β-agonists
75 β2-agonist use
76 schema:name Systematic review of clinical outcomes in chronic obstructive pulmonary disease
77 schema:pagination 219-230
78 schema:productId N17aa9565c9244f2a89e798afbee6afdf
79 Nb968cccb215a48f4a2e8817d0616c8d2
80 Ncd46c62a0d864e279c34bcc0b9e4be4e
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026725163
82 https://doi.org/10.1385/criai:31:2:219
83 schema:sdDatePublished 2022-12-01T06:26
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher Nee0653c463484424bdbfce8a833db8e1
86 schema:url https://doi.org/10.1385/criai:31:2:219
87 sgo:license sg:explorer/license/
88 sgo:sdDataset articles
89 rdf:type schema:ScholarlyArticle
90 N045553b0b1b04666b05a1ce6702d0490 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Humans
92 rdf:type schema:DefinedTerm
93 N0bd0987588e544ae9b67a778ca80d3eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Drug Therapy, Combination
95 rdf:type schema:DefinedTerm
96 N16fa8518cb3842f28df4e1246679437a rdf:first sg:person.01076436625.24
97 rdf:rest rdf:nil
98 N17aa9565c9244f2a89e798afbee6afdf schema:name doi
99 schema:value 10.1385/criai:31:2:219
100 rdf:type schema:PropertyValue
101 N1d6c3bdb0b714ed1bf9f54cfecb32f0d schema:volumeNumber 31
102 rdf:type schema:PublicationVolume
103 N255da2cdafc74749b24e8bd5af34552c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Adrenal Cortex Hormones
105 rdf:type schema:DefinedTerm
106 N358d988dc49545b8b2793bf6e8a0007f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Administration, Inhalation
108 rdf:type schema:DefinedTerm
109 N3d8538736da345619687d64686b4eff0 rdf:first sg:person.012160071167.38
110 rdf:rest N16fa8518cb3842f28df4e1246679437a
111 N77e1a4ba2f8d40839264e916aed67d7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Pulmonary Disease, Chronic Obstructive
113 rdf:type schema:DefinedTerm
114 N8e5f1172d93141f2ac0dff2bf2864c6c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Cholinergic Antagonists
116 rdf:type schema:DefinedTerm
117 Nb968cccb215a48f4a2e8817d0616c8d2 schema:name dimensions_id
118 schema:value pub.1026725163
119 rdf:type schema:PropertyValue
120 Ncbd2296ba6114b309c2a02476ef3d85e schema:issueNumber 2-3
121 rdf:type schema:PublicationIssue
122 Ncd46c62a0d864e279c34bcc0b9e4be4e schema:name pubmed_id
123 schema:value 17085795
124 rdf:type schema:PropertyValue
125 Nee0653c463484424bdbfce8a833db8e1 schema:name Springer Nature - SN SciGraph project
126 rdf:type schema:Organization
127 Nf2e3171637a84a75ba40dbd51194ea9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Treatment Outcome
129 rdf:type schema:DefinedTerm
130 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
131 schema:name Medical and Health Sciences
132 rdf:type schema:DefinedTerm
133 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
134 schema:name Cardiorespiratory Medicine and Haematology
135 rdf:type schema:DefinedTerm
136 sg:journal.1094155 schema:issn 1080-0549
137 1559-0267
138 schema:name Clinical Reviews in Allergy & Immunology
139 schema:publisher Springer Nature
140 rdf:type schema:Periodical
141 sg:person.01076436625.24 schema:affiliation grid-institutes:None
142 schema:familyName Buckley
143 schema:givenName Nicholas S.
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076436625.24
145 rdf:type schema:Person
146 sg:person.012160071167.38 schema:affiliation grid-institutes:grid.415182.b
147 schema:familyName Salpeter
148 schema:givenName Shelley R.
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012160071167.38
150 rdf:type schema:Person
151 sg:pub.10.1038/2211251a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053619986
152 https://doi.org/10.1038/2211251a0
153 rdf:type schema:CreativeWork
154 sg:pub.10.1111/j.1525-1497.2006.00507.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1030196607
155 https://doi.org/10.1111/j.1525-1497.2006.00507.x
156 rdf:type schema:CreativeWork
157 sg:pub.10.1186/1471-2466-4-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024041024
158 https://doi.org/10.1186/1471-2466-4-7
159 rdf:type schema:CreativeWork
160 sg:pub.10.1186/1471-2466-5-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009077314
161 https://doi.org/10.1186/1471-2466-5-3
162 rdf:type schema:CreativeWork
163 sg:pub.10.2165/00002018-199207010-00007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053525213
164 https://doi.org/10.2165/00002018-199207010-00007
165 rdf:type schema:CreativeWork
166 sg:pub.10.2165/00002512-200421060-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044511580
167 https://doi.org/10.2165/00002512-200421060-00005
168 rdf:type schema:CreativeWork
169 sg:pub.10.2165/00044011-200121120-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040752590
170 https://doi.org/10.2165/00044011-200121120-00006
171 rdf:type schema:CreativeWork
172 sg:pub.10.2165/00151829-200403040-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042323565
173 https://doi.org/10.2165/00151829-200403040-00005
174 rdf:type schema:CreativeWork
175 grid-institutes:None schema:alternateName International Baccalaureate Program, Sequoia High School, Redwood City, CA
176 schema:name International Baccalaureate Program, Sequoia High School, Redwood City, CA
177 rdf:type schema:Organization
178 grid-institutes:grid.415182.b schema:alternateName Santa Clara Valley Medical Center, San Jose, CA
179 schema:name Department of Medicine, Stanford University School of Medicine, Stanford
180 Santa Clara Valley Medical Center, San Jose, CA
181 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...